Lista de obras - Jill Anderson - Dominio Público Uruguay

Absence of bilateral vision loss from amiodarone: a randomized trial

artículo científico publicado en 2007

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

artículo científico publicado en 2005

An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial

artículo científico publicado en 2010

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2006

Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2008

Home use of automated external defibrillators for sudden cardiac arrest

artículo científico publicado en 2008

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

artículo científico publicado en 2009

Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2008

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population

artículo científico publicado en 2009

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2008

No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial

artículo científico publicado en 2013

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial

artículo científico publicado en 2008

Prognostic importance of defibrillator shocks in patients with heart failure

artículo científico publicado en 2008

Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)

artículo científico publicado en 2010

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2013

Rationale and design of the Home Automatic External Defibrillator Trial (HAT).

artículo científico publicado en 2008

Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients

artículo científico publicado en 2014

Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial

artículo científico publicado en 2013

Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial”

Response to Letter Regarding Article, “Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)”

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure

artículo científico publicado en 2006

SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death

artículo científico publicado en 2015

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

artículo científico publicado en 2007

Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study

artículo científico publicado en 2008

Thyroid function in heart failure and impact on mortality

artículo científico publicado en 2013

Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2014

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

artículo científico publicado en 2014

Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2007

Lista de obras de Jill Anderson

Absence of bilateral vision loss from amiodarone: a randomized trial

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Home use of automated external defibrillators for sudden cardiac arrest

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial

Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial

Prognostic importance of defibrillator shocks in patients with heart failure

Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT)

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Rationale and design of the Home Automatic External Defibrillator Trial (HAT).

Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients

Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial

Response to Letter Regarding Article, “Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial”

Response to Letter Regarding Article, “Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)”

Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure

SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death

Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study

Thyroid function in heart failure and impact on mortality

Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).